These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 110933)

  • 21. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.
    Stacpoole PW; Harwood HJ; Varnado CE
    J Clin Invest; 1983 Nov; 72(5):1575-85. PubMed ID: 6630519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effect of clofibrate on hepatic HMG-CoA reductase activity in young swine in the postabsorptive state.
    Kim DN; Rogers DH; Reiner JM; Lee KT; Thomas WA
    Exp Mol Pathol; 1976 Dec; 25(3):301-10. PubMed ID: 1001403
    [No Abstract]   [Full Text] [Related]  

  • 24. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine inhibits hepatic cholesterol synthesis and microsomal 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA reductase) activity.
    Ottery FD; Goldfarb S
    FEBS Lett; 1976 May; 64(2):346-9. PubMed ID: 179885
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of NADPH-cytochrome c reductase in microsomal hydroxylation reactions.
    Prough RA; Burke MD
    Arch Biochem Biophys; 1975 Sep; 170(1):160-8. PubMed ID: 809012
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytochrome P450 mediated drug metabolism in the streptozotocin diabetic rat.
    Faas FH; Carter WJ
    Horm Metab Res; 1980 Dec; 12(12):706-7. PubMed ID: 6782003
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.
    König B; Koch A; Spielmann J; Hilgenfeld C; Stangl GI; Eder K
    Biochem Pharmacol; 2007 Feb; 73(4):574-85. PubMed ID: 17126302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of clofibrate and its analogs in rats. Dissociation of hypolipidemic effects and the induction of peroxisomal beta-oxidation.
    Harrison EH
    Biochim Biophys Acta; 1984 Nov; 796(2):163-8. PubMed ID: 6541949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 31P-NMR of liver peroxisome membranes from normal and clofibrate-treated rats.
    Serafini B; Cimini A; Sette M; Sartori C
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):479-89. PubMed ID: 8397028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
    Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
    Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E; Paris R
    Reprod Nutr Dev (1980); 1980; 20(3A):637-45. PubMed ID: 7349434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
    Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA
    J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some effects of selenium deficiency on the hepatic microsomal cytochrome P-450 system in the rat.
    Burk RF; Masters BS
    Arch Biochem Biophys; 1975 Sep; 170(1):124-31. PubMed ID: 809011
    [No Abstract]   [Full Text] [Related]  

  • 38. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.
    Haughom B; Spydevold O
    Biochim Biophys Acta; 1992 Sep; 1128(1):65-72. PubMed ID: 1327145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amides of beta-(4-chlorophenoxy)-alpha-phenyl-ethylamines are inhibitors of cholesterol biosynthesis in vitro.
    Rossi S; Diamantini G; Pescador R
    Farmaco; 1989 Mar; 44(3):315-21. PubMed ID: 2775418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clofibrate selectively induces azoreduction of dimethylaminoazobenzene (DAB) by rat liver microsomes.
    Levine WG; Raza H
    Adv Exp Med Biol; 1986; 197():861-70. PubMed ID: 3094343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.